GD

Gaurav Dhamija

Director Director DIN 02613484
DIN 02613484 First appointment Apr 2009 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Apr 2009
Shareholding value Locked Premium profile

About Gaurav Dhamija

Data last updated:

Gaurav Dhamija has 17 years in corporate governance. Formerly with 1 company, such as Cosmovet Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 02613484
Primary Designation Director
First Appointment 13 Apr 2009
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Cosmovet Pharma Private Limited U24233HR2008PTC038321
Director13 Apr 20092008Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Cosmovet Pharma Private Limited
Premium access

Shareholding and investment profile for Gaurav Dhamija

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gaurav Dhamija

Gaurav Dhamija has 17 years in corporate governance. Formerly with 1 company, such as Cosmovet Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Gaurav Dhamija is associated with 0 companies as a director.

Gaurav Dhamija has expertise in General Business.

Gaurav Dhamija has 17 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available